Following the investment philosophies of the world’s best investors is a really smart idea for beginner and seasoned investors alike. That’s not to say you replicate their portfolios blindly, but tracking what stocks top investors have been buying lately is not only a good way to find new stock ideas to research but also to back up your own thesis on a stock you may already own.
So we asked three Motley Fool contributors to pick a stock famed investors are currently buying. Here’s why Cummins (NYSE:CMI), CenturyLink (NYSE:CTL), and Southwest Airlines (NYSE:LUV) caught their attention.
Keep on truckin’
Neha Chamaria (Cummins): When the world’s largest hedge fund makes a move, it warrants attention regardless of the size of the investment. Ray Dalio’s Bridgewater Associates, which manages nearly $150 billion worth of investments, added a new stock to its portfolio during the second quarter: Cummins. The fund now owns shares worth roughly $31.3 million, or 235,261 shares of the engine manufacturer. That’s more than the number of shares it owns in Caterpillar, a stock it’s been invested in for several quarters now and added to in Q2.
Top 5 Safest Stocks For 2021: Contango Oil & Gas Company(MCF)
We are a Houston, Texas based independent oil and natural gas company. Our business is to maximize production and cash flow from our offshore properties in the shallow waters of the Gulf of Mexico (“GOM”) and onshore properties in various plays, and use that cash flow to explore, develop, exploit and acquire crude oil and natural gas properties in the onshore Texas Gulf Coast and Rocky Mountain regions of the United States.
On October 1, 2013, we completed a merger with Crimson Exploration Inc. (“Crimson”), in an all-stock transaction pursuant to which Crimson became a wholly-owned subsidiary of Contango (the “Merger”). Accordingly, we issued approximately 3.9 million shares of common stock in exchange for all of Crimson’s outstanding capital stock, resulting in Crimson stockholders owning 20.3% of the post-Merger Contango.
On October 1, 2013, our board of directors approved a change in fiscal year end from June 30 to December 31. Advisors’ Opinion:
- [By Ethan Ryder]
Fmr LLC increased its position in shares of Contango Oil & Gas (NYSEAMERICAN:MCF) by 33.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,583,039 shares of the oil and natural gas company’s stock after buying an additional 899,900 shares during the quarter. Fmr LLC owned 13.93% of Contango Oil & Gas worth $20,352,000 at the end of the most recent quarter.
- [By Joseph Griffin]
Fondren Management LP purchased a new position in shares of Contango Oil & Gas (NYSEAMERICAN:MCF) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 60,000 shares of the oil and natural gas company’s stock, valued at approximately $341,000. Fondren Management LP owned 0.23% of Contango Oil & Gas as of its most recent filing with the SEC.
- [By Joseph Griffin]
Contango Oil & Gas (NASDAQ:MCF) was downgraded by equities researchers at Seaport Global Securities from a “buy” rating to a “neutral” rating in a research report issued on Friday.
- [By Stephan Byrd]
COPYRIGHT VIOLATION NOTICE: “Contango Oil & Gas (MCF) Short Interest Update” was originally published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at www.tickerreport.com/banking-finance/3346537/contango-oil-gas-mcf-short-interest-update.html.
Top 5 Safest Stocks For 2021: Catalyst Pharmaceuticals, Inc.(CPRX)
Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. The Company has three drugs in development: Firdapse, CPP-109 and CPP-115.
Firdapse
The Company’s Firdapse is indicated for the treatment of lambert-eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes (CMS). Firdapse consists of the phosphate salt of amifampridine. The Company has completed the Phase III trial of Firdapse. The Phase III trial was designed as a double blind, randomized withdrawal trial in which all patients were initially treated with Firdapse during a 91-day run-in period followed by treatment with either Firdapse or placebo during a two-week randomization period.
CPP-109
The Company’s CPP-109 (vigabatrin) is a gamma-aminobutyric acid (GABA) aminotransferase inhibitor. CPP-109 is indicated for the treatment of Tourette’s Disorder. Vigabatrin is approved for human use (Sabril and Lundbeck) and CPP-109 is being employed as a research surrogate for exploring potential indications for which there are no adequate animal models.
CPP-115
The Company’s CPP-115 is a GABA aminotransferase inhibitor. CPP-115 is indicated for the treatment of selected neurological indications, such as complex partial seizures and Tourette’s Disorder, and epilepsy. The Company has completed the Phase Ib multi-dose safety and tolerance study of CPP-115. CPP-115 has been granted Orphan Drug Designation by the food and drug administration (FDA) for the treatment of infantile spasms and Orphan Medicinal Product Designation in the European Union, for West syndrome (a form of infantile spasms).
The Company competes with Jacobus Pharmaceutical, Pfizer, J&J, UCB, Abbott, GSK, Roche and Novartis.
Advisors’ Opinion:
- [By Motley Fool Transcribers]
Catalyst Pharmaceuticals Inc(NASDAQ:CPRX)Q12019 Earnings CallMay. 13, 2019, 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Motley Fool Transcribers]
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)Q42018 Earnings Conference CallMarch 19, 2019, 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Stephan Byrd]
BidaskClub cut shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) from a hold rating to a sell rating in a report published on Tuesday.
CPRX has been the subject of several other research reports. HC Wainwright set a $6.00 target price on Catalyst Pharmaceuticals and gave the stock a buy rating in a research report on Wednesday, August 22nd. Zacks Investment Research raised Catalyst Pharmaceuticals from a hold rating to a buy rating and set a $3.25 target price for the company in a research report on Monday, August 13th. Oppenheimer started coverage on Catalyst Pharmaceuticals in a research report on Thursday, July 12th. They issued a buy rating and a $6.00 target price for the company. Cantor Fitzgerald started coverage on Catalyst Pharmaceuticals in a research report on Friday, September 21st. They issued an overweight rating for the company. Finally, Piper Jaffray Companies started coverage on Catalyst Pharmaceuticals in a research report on Friday, September 7th. They issued an overweight rating and a $5.00 target price for the company. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. The company has an average rating of Hold and an average price target of $5.61.
- [By Joseph Griffin]
Cantor Fitzgerald assumed coverage on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) in a report issued on Thursday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $8.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 153.97% from the stock’s current price.
Top 5 Safest Stocks For 2021: Unifi, Inc.(UFI)
Unifi, Inc., incorporated on January 8, 1969, is a manufacturing company. The Company processes and sells commodity yarns, specialized yarns and premier value-added (PVA) yarns. The Company operates through three segments: Polyester segment, Nylon segment and International segment. The Company’s polyester products include polyester polymer beads (Chip), partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed and draw wound yarns, which is available in virgin or recycled varieties (the latter made from both pre-consumer yarn waste and post-consumer waste, including plastic bottles). The Company’s nylon products include textured, solution dyed and spandex covered products. The Company’s principal geographic markets for its products are located in the United States, Canada, Mexico, Central America and South America.
Polyester
The Company’s Polyester segment manufactures Chip, POY, textured, dyed, twisted, beamed and draw wound yarns, both virgin and recycled, with sales primarily to other yarn manufacturers and knitters and weavers that produce yarn and/or fabric for the apparel, hosiery, automotive upholstery, home furnishings, industrial and other end-use markets. The Polyester Segment consists of sales and manufacturing operations in the United States and El Salvador.
Nylon
The Company’s Nylon segment manufactures textured yarns (both nylon and polyester) and spandex covered yarns, with sales to knitters and weavers that produce fabric primarily for the apparel and hosiery markets. The Nylon Segment consists of sales and manufacturing operations in the United States and Colombia.
International
The Company’s International segment offers products, including textured polyester, and various types of resale yarns and staple fiber. The International Segment sells its yarns to knitters and weavers that produce fabric for the apparel, automotive upholstery, home furnishings, industrial and other end-use m! arkets primarily in the South American and Asian regions. It also includes a manufacturing location and sales offices in Brazil and a sales office in China.
The Company competes with O’Mara, Inc., NanYa Plastics Corp. of America, AKRA, S.A. de C.V., C S Central America S.A. de C.V., Avanti Industria Comercio Importacao e Exportacao Ltda., Polyenka Ltda., Sapona Manufacturing Company, Inc. and McMichael Mills, Inc.
Advisors’ Opinion:
- [By Stephan Byrd]
Unifi, Inc. (NYSE:UFI) Director Robert J. Bishop purchased 4,000 shares of Unifi stock in a transaction dated Friday, August 31st. The stock was bought at an average price of $31.79 per share, with a total value of $127,160.00. Following the completion of the purchase, the director now directly owns 10,288 shares of the company’s stock, valued at $327,055.52. The purchase was disclosed in a legal filing with the SEC, which is available through this link.
Top 5 Safest Stocks For 2021: iShares S&P Global Clean Energy Index Fund(ICLN)
iShares Global Clean Energy ETF, formerly iShares S&P Global Clean Energy Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Global Clean Energy Index. The S&P Global Clean Energy Index includes clean energy production companies, clean energy equipment and technology providers. The Fund operates in a range of sectors, which include electric utilities, semiconductors and semiconductor equipment, independent power producers and energy traders, commercial services and supplies, and electrical equipment. BlackRock Fund Advisors acts as an investment adviser. Advisors’ Opinion:
- [By Scott Levine]
For those afraid of getting burned with the solar ETF, the iShares Global Clean Energy ETF (NASDAQ:ICLN)may be a more attractive option since the fund’s stated objective is to “track the investment results of the S&P Global Clean Energy Index.” The fund’s 30 holdings represent global leaders in renewable energy, ranging from solar power to geothermal to waste-to-energy. Like the Invesco Solar ETF, the iShares Global Clean Energy ETF is not actively managed and carries a fairly low expense ratio of 0.47%. Distributions are made semiannually and currently offer a trailing-12-month yield of 2.34%.
Top 5 Safest Stocks For 2021: CenturyLink, Inc.(CTL)
CenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers in the United States. It operates through two segments, Business and Consumer. The company offers high-speed Internet services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; multi-protocol label switching, a data networking technology to support real-time voice and video; and private line services for the transmission of data between sites. It also provides Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions across metropolitan areas and wide area networks (WAN); colocation services that enable its customers to install their own information technology (IT) equipment; and managed hosting services comprising cloud and traditional computing, application management, back-up, storage, and other services. In addition, the company offers video entertainment services and satellite digital television; Voice over Internet Protocol, a real-time, two-way voice communication service; and managed services that consist of network, hosting, cloud, and IT services. Further, it provides local calling, long-distance voice, integrated services digital network, WAN, and switched access services; and data integration, which includes the sale of telecommunications equipment and providing network management, installation, and maintenance of data equipment, and the building of proprietary fiber-optic broadband networks. Additionally, the company leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2015, it served approximately 6 million high-speed Internet subscribers and 285 thousand television subscribers; and operated 59 data centers in North America, Europe, and Asia. CenturyLink, Inc. was founded in 1968 and is headquartered in Monroe, Louisiana.
